Federal Register Final rule: FDA is amending the animal drug regulations to reflect a change of sponsor for three approved new animal drug applications Orbenin DC (cloxacillin benzathine), Dariclox (cloxacillin sodium), Amoxi-Mast (amoxicillin trihydrate) from Pfizer, Inc., to Schering-Plough Animal Health Corp. To view this final rule, click here.
